Compare Cardinal Health Inc (CAH) vs Microsoft (MSFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Microsoft — how do they compare? Cardinal Health Inc trades at $229.02 (market cap $53.89B), while Microsoft trades at $398.08 (market cap $2.86T). The key difference: Microsoft is far larger — about 53.1× Cardinal Health Inc's market cap, and Microsoft pays the higher dividend (0.95%). Which is the better fit depends on your goals.
| CAH | MSFT | |
|---|---|---|
Market Cap | $53.89B | $2.86T |
Sector | Health | Technology |
52-Week High | $239.71 | $542.07 |
52-Week Low | $146.04 | $352.83 |
Enterprise Value | $58.87B | $2.84T |
Dividend Yield | 0.89% | 0.95% |
Volume | — | 36,654,621 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Microsoft (MSFT) trades at $397.36, up 1.63% today, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $4.27 exceeding the $4.06 estimate. Revenue grew to $281.72B in 2025, and net income reached $101.83B. Analyst consensus is strongly bullish with an 80.49% buy rating and a $551.62 price target. Recent news highlights AI leadership and Azure growth, though concerns over capital expenditures persist.
Outlook: MSFT's AI integration and cloud dominance support long-term growth, but high valuation and spending fears pose risks. The stock offers upside to analyst targets, yet investors face volatility from tech sector rotation and macroeconomic pressures. Balanced view: fundamentals justify holding, but entry near support levels may reduce risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →
